Lv4
736 积分 2023-05-30 加入
On some aspects of validation of predictive quantitative structure–activity relationship models
3个月前
已完结
Introduction to 3D-QSAR
3个月前
已完结
Catalytic in vivo protein knockdown by small-molecule PROTACs
3个月前
已完结
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases
3个月前
已完结
Challenges and Opportunities in Psoriatic Disease: An Integrated View of the Future
5个月前
已关闭
Patients, physicians, and progress: Lessons from the history of the National Psoriasis Foundation
5个月前
已关闭
Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease
9个月前
已完结
A derivative of tanshinone IIA and salviadione, 15a, inhibits inflammation and alleviates DSS-induced colitis in mice by direct binding and inhibition of RIPK2
9个月前
已完结
Discovery of Potent and Balanced Dual RIPK2 and 3 Inhibitors as a New Strategy for the Treatment of Inflammatory Bowel Diseases
9个月前
已完结
Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs)
9个月前
已完结
皖公网安备34019202002308
